guest ::
| Home > Publications Database > Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis. > print |
| Home > Publications Database > Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis. > print |
| 001 | 165272 | ||
| 005 | 20250127111044.0 | ||
| 024 | 7 | _ | |a 10.1111/ene.15584 |2 doi |
| 024 | 7 | _ | |a pmid:36169607 |2 pmid |
| 024 | 7 | _ | |a 1351-5101 |2 ISSN |
| 024 | 7 | _ | |a 1468-1331 |2 ISSN |
| 024 | 7 | _ | |a 1471-0552 |2 ISSN |
| 024 | 7 | _ | |a altmetric:136585921 |2 altmetric |
| 037 | _ | _ | |a DZNE-2022-01565 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Xia, Kailin |0 P:(DE-2719)9001677 |b 0 |u dzne |
| 245 | _ | _ | |a Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis. |
| 260 | _ | _ | |a Oxford |c 2023 |b Blackwell Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1708965560_5085 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a ISSN 1468-1331 not unique: **2 hits**. |
| 520 | _ | _ | |a Growing evidence shows that ALS patients feature a disturbed energy metabolism. However, these features have rarely been investigated in the presymptomatic stage.A total of 60 presymptomatic ALS mutation carriers and 70 age- and gender-matched controls (non-mutation carriers from the same families) were recruited. All subjects underwent assessments of their metabolic profiles under fasting conditions at enrollment, including body mass index (BMI), blood pressure and serum levels of blood glucose, total cholesterol, triglycerides, high-density lipoprotein (HDL) and low-density lipoprotein.All mutations combined, no differences between presymptomatic ALS gene carriers and controls were found. From a cardiovascular point of view, presymptomatic chromosome 9 open reading frame 72 (C9ORF72) gene carriers showed lower cardiovascular risk profiles compared to healthy controls, including lower BMI (median 22.9, interquartile range [IQR] 20.6-26.1 kg/m2 vs. 24.9, IQR 22.7-30.5 kg/m2 ; p = 0.007), lower systolic blood pressure (120, IQR 110-130 mmHg vs. 128, IQR 120-140 mmHg; p = 0.02), lower fasting serum glucose (89.0, IQR 85.0-97.0 mg/dl vs. 96.0, IQR 89.3-102.0 mg/dl; p = 0.005) and higher HDL (1.6, IQR 1.3-1.8 mmol/l vs. 1.2, IQR 1.0-1.4 mmol/l; p = 0.04). However, presymptomatic superoxide dismutase 1 (SOD1) gene mutation carriers showed higher cardiovascular risk profiles compared to healthy controls, including higher BMI (28.0, IQR 26.1-31.5 kg/m2 vs. 24.9, IQR 22.7-30.5 kg/m2 ; p = 0.02), higher fasting serum glucose (100.0, IQR 94.0-117.0 mg/dl vs. 96.0, IQR 89.3-102.0 mg/dl; p = 0.04) and lower HDL (1.2, IQR 1.0-1.4 mmol/l vs. 1.4, IQR 1.2-1.7 mmol/l; p = 0.01). These features were most prominent in patients carrying SOD1 gene mutations associated with slow disease progression.This study identified distinct metabolic profiles in presymptomatic ALS gene carriers, which might be associated with disease progression in the symptomatic phase. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 542 | _ | _ | |i 2022-10-17 |2 Crossref |u http://creativecommons.org/licenses/by-nc/4.0/ |
| 542 | _ | _ | |i 2022-10-17 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Amyotrophic lateral sclerosis |2 Other |
| 650 | _ | 7 | |a Genetics |2 Other |
| 650 | _ | 7 | |a Metabolism |2 Other |
| 650 | _ | 7 | |a Presymptomatic Gene Carriers |2 Other |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: genetics |2 MeSH |
| 650 | _ | 2 | |a Superoxide Dismutase-1: genetics |2 MeSH |
| 650 | _ | 2 | |a Blood Glucose |2 MeSH |
| 650 | _ | 2 | |a Disease Progression |2 MeSH |
| 650 | _ | 2 | |a Metabolome |2 MeSH |
| 700 | 1 | _ | |a Witzel, Simon |0 P:(DE-2719)9001976 |b 1 |u dzne |
| 700 | 1 | _ | |a Witzel, Christina |b 2 |
| 700 | 1 | _ | |a Klose, Veronika |0 P:(DE-2719)9001084 |b 3 |u dzne |
| 700 | 1 | _ | |a Fan, Dongsheng |0 0000-0002-6679-0864 |b 4 |
| 700 | 1 | _ | |a Ludolph, Albert C |0 P:(DE-2719)2812633 |b 5 |e Last author |u dzne |
| 700 | 1 | _ | |a Dorst, Johannes |0 P:(DE-2719)9001951 |b 6 |u dzne |
| 773 | 1 | 8 | |a 10.1111/ene.15584 |b Wiley |d 2022-10-17 |n 1 |p 87-95 |3 journal-article |2 Crossref |t European Journal of Neurology |v 30 |y 2022 |x 1351-5101 |
| 773 | _ | _ | |a 10.1111/ene.15584 |g p. ene.15584 |0 PERI:(DE-600)2020241-6 |n 1 |p 87-95 |t European journal of neurology |v 30 |y 2023 |x 1351-5101 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/165272/files/DZNE-2022-01565.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/165272/files/DZNE-2022-01565.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:165272 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9001677 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-2719)9001976 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9001084 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2812633 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 6 |6 P:(DE-2719)9001951 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-22 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J NEUROL : 2022 |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-22 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-22 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J NEUROL : 2022 |d 2023-10-22 |
| 920 | 1 | _ | |0 I:(DE-2719)5000077 |k Clinical Study Center Ulm |l Clinical Study Center Ulm |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1910005 |k AG Zhan |l Neuroepidemiology |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)5000077 |
| 980 | _ | _ | |a I:(DE-2719)1910005 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/ene.14393 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3389/fnins.2020.00042 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuron.2018.02.027 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S1474-4422(10)70224-6 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.40.6.533 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3109/17482960902822960 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/01.wnl.0000285080.70324.27 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1620/tjem.139.365 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/ajcn/74.3.328 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jns.2020.117257 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-009-5100-z |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/aje/kww140 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s10654-017-0318-z |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/WNL.53.5.1059 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.2010.211474 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1096/fj.02-1182fje |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1001/archneurol.2010.128 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp-2017-315795 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s40478-014-0171-1 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.25661 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp-2020-323372 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0140-6736(14)60222-1 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s10072-021-05099-0 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3389/fneur.2020.567753 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mus.25547 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1194/jlr.M700017-JLR200 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.15252/emmm.201404433 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.0402026101 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3390/nu13072273 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/WNL.0000000000009322 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3389/fneur.2019.00191 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awr366 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s40035-021-00266-x |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp-2016-313521 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/hmg/dds188 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuron.2004.06.021 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3390/ijms21186606 |2 Crossref |
| 999 | C | 5 | |1 Günther R |y 2022 |2 Crossref |o Günther R 2022 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-021-10716-1 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/aww004 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.expneurol.2005.07.020 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1371/journal.pone.0005390 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.bbadis.2009.08.012 |2 Crossref |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.4103/0366-6999.172561 |2 Crossref |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|